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Abstract Genes encoding adipokines are considered as
candidates for human obesity. In this study we analyzed the
expression of leptin (LEP) and adiponectin (ADIPOQ)
genes in relation to common 50-ﬂanking or 50UTR variants:
-2548G[A( LEP), 19A[G( LEP) and -11377C[G( ADI-
POQ) in Polish obese children and adolescents. Relative
transcription levels in the subcutaneous adipose tissue (real
time RT–PCR) and serum protein concentrations (RIA)
were measured in 48 obese subjects with known genotypes
at three polymorphic sites and in ﬁve non-obese controls.
None of the studied polymorphisms altered signiﬁcantly
the expression. Signiﬁcantly elevated relative transcription
levels of the LEP gene (P\0.05) and serum leptin con-
centrations (P\0.01) were recorded in obese patients,
when compared with the non-obese controls, but such
differences were not found for the ADIPOQ gene.
Interestingly, the leptin to adiponectin protein concentra-
tion ratio (L/A) was approximately sevenfold higher in
obese children and adolescents when compared with the
non-obese controls (P\0.001). Taking into consideration
the observed relationship between the genotypes and the
gene expression level we suggest that these SNPs are not
conclusive markers for predisposition to obesity in Polish
children and adolescents. On the other hand, we conﬁrmed
that the leptin to adiponectin gene expression ratio (L/A) is
an informative index characterizing obesity.
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Introduction
An incidence of obesity varies within a wide range when
different countries or ethnic populations are considered.
Recent investigations showed that in several countries (e.g.
the USA, Australia, Japan and some European countries)
the observed epidemic of childhood and adolescence
obesity is leveling off, but generally it still remains at a
high, unacceptable level [1]. An excessive deposition of
adipose tissue, which plays an important endocrine func-
tion, is associated with the role of adipokines (e.g. leptin
and adiponectin) in the regulation of energy homeostasis
[2, 3]. Thus, the search for adipokine gene mutations has
become an obvious target in studies on molecular markers
predisposing to obesity. Unfortunately, molecular studies
revealed that the incidence of causal mutations of adipo-
kine genes is very low. Until now, only several functional
nonsynonymous polymorphisms were identiﬁed in the
leptin gene [4–6]. On the other hand, studies of adipose
tissue are also important since the adipocytes are
J. Cieslak   M. Bartz   M. Stachowiak   M. Switonski (&)
Department of Genetics and Animal Breeding,
Poznan University of Life Sciences, Wolynska 33,
60-637 Poznan, Poland
e-mail: switonsk@jay.up.poznan.pl
B. Skowronska   K. A. Majewska   W. Stankiewicz   P. Fichna
Department of Pediatric Diabetes and Obesity,
Poznan University of Medical Sciences, Szpitalna 27/33,
60-572 Poznan, Poland
K. A. Majewska
Department of Pediatric Nursing, Poznan University
of Medical Sciences, Szpitalna 27/33,
60-572 Poznan, Poland
J. Harasymczuk
Department of Pediatric Surgery, Traumatology and Urology,
Poznan University of Medical Sciences, Szpitalna 27/33,
60-572 Poznan, Poland
123
Mol Biol Rep (2012) 39:3951–3955
DOI 10.1007/s11033-011-1174-7considered as a promising source of stem cells for potential
use in regenerative medicine [7].
An altered endocrine function of the adipose tissue,
associated with obesity, can also be caused by an abnormal
level of gene expression due to mutations in regulatory
sequences of genes encoding adipokines. Analysis of the
transcription proﬁle in the fat tissue originating from obese
and non-obese subjects revealed wide differences in terms
of the number of up- and down-regulated genes (for review
see: [8]). There are also reports indicating an association
between obesity and some polymorphisms in the 50-ﬂank-
ing regions of the leptin (LEP) and adiponectin (ADIPOQ)
genes; however, the conclusions are not consistent [9–13].
In our recent studies of obese children and adolescents we
detected 9 polymorphic sites in the 50-ﬂanking region of the
LEP and 2 in the 50-ﬂanking region of the ADIPOQ genes
[14], but the frequency of these variants did not differ in a
cohort of obese patients when compared with non-obese
ones. The effect of polymorphism in the 50-ﬂanking regions
of genes encoding adiponectin and leptin was reported
in several studies. The following polymorphisms were
considered: -2548G[A( LEP), -11377C[T, -11391G[A
(ADIPOQ)[ 12, 15–17]. Also polymorphism in 50UTR of
the LEP gene (19A[G) was investigated with regard to the
circulating leptin level [18, 19].
The aim of this study was to compare the transcription
level of the LEP and ADIPOQ genes in the subcutaneous
adipose tissue, as well as serum leptin and adiponectin
concentrations, in Polish obese children and adolescents
with different genotypes at three polymorphic sites in the
50-ﬂanking or 50UTR sequences: -2548G[A (rs7799039)
(LEP), 19A[G (rs2167270) (LEP) and -11377C[G
(rs266729) (ADIPOQ). Moreover, the expression level of
both genes as well as the leptin to adiponectin ratio (L/A)
were compared in obese patients and non-obese controls.
Materials and methods
Patients
Altogether 53 blood and subcutaneous adipose tissue
samples were collected from patients (48 obese children or
adolescents and ﬁve non-obese children as the control) of
the Department of Pediatric Diabetes and Obesity, Poznan
University of Medical Sciences (Poznan, Poland) and the
study was approved by the local Bio-Ethics Committee at
the Poznan University of Medical Sciences. The cohort of
obese patients consisted of 23 boys and 25 girls (mean age:
11.9 ± 3.3). The control group consisted of ﬁve healthy
and non-obese children. After recording of basic parame-
ters (age, gender, body mass and height) their relative BMI
(RBMI) was calculated as described before [20]. Mean
RBMI for obese patients was 164.2 ± 20.6, while in case
of controls was below 110.
Molecular and statistical analyses
Total RNA from the subcutaneous adipose tissue was iso-
lated using an RNasy Lipid Tissue Mini Kit (Qiagen, USA)
according to the manufacturer’s protocol and 1 lg of RNA
was used for reverse transcription (cDNA synthesis). The
relative transcription level of the LEP and ADIPOQ genes
was measured (by real-time PCR) in duplicate using a
SybrGreen (Roche) detection (LightCycler 2.0, Roche). The
relative mRNA abundance was normalized to the GAPDH
reference gene which reveals high expression stability in
human adipose tissue and is commonly used in studies of
adipokines genes [21, 22]. For real-time PCR ampliﬁcation
we used the following primer pairs: ADIPOQ-F-ccatctcctc
ctcacttcc, ADIPOQ-R-atgaccgggcagagctaata, LEP-F-aaccct
gtgcggattcttgtgg, LEP-R-ccggtgactttctgtttggaggag, GAP-
DH-F- gagccacatcgctcagacac and GAPDH-R-catgtagttgag
gtcaatgaa. The primers were designed with the use of Pri-
mer3 software (http://frodo.wi.mit.edu/primer3/).
Cycling conditions for all ampliﬁed genes were: 95C
for 10 min (preliminary denaturation), 40 cycles of 95C
for 10 s (denaturation), 63C for 2 s (annealing) and 72C
for 6 s (elongation) each. Serum adiponectin and leptin
concentrations in all investigated patients were measured
with the application of radioimmunoassay (RIA) using
commercial kits (Millipore, USA).
For statistical analysis the R package (version 2.12.0)
(http://www.r-project.org/) was applied. Differences in
leptin and adiponectin relative mRNA levels, serum pro-
teins concentrations as well as in leptin to adiponectin ratio
(L/A) between lean and obese subjects were measured
using the Wilcoxon Rank Sum Test. The LEP and
ADIPOQ gene expression between patients carrying dif-
ferent genotypes in the 50-ﬂanking polymorphic sites was
compared in additive, dominant and recessive models using
Kruskal–Wallis or Wilcoxon Rank Sum Test. Estimated
P-values were adjusted for multiple testing using Bonfer-
roni correction.
Results
Analysis of the correlation between ADIPOQ and LEP
genes expression, measured at mRNA and protein con-
centration level, as well as between their expression and
RBMI value did not show highly signiﬁcant results, puta-
tively due to a relatively small number of investigated
patients. The strongest correlation (r = 0.28; P = 0.05)
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concentration of leptin. In addition, correlation between
adiponectin serum concentration and RBMI was close to
signiﬁcancy (r =- 0.27; P = 0.06).
A comparison of relative transcription levels in sub-
cutaneous fat depots as well as the analysis of LEP and
ADIPOQ protein serum concentrations revealed the sig-
niﬁcantly elevated expression of the ﬁrst in the group of
obese children and adolescents. Such differences were not
observed for adiponectin mRNA and protein. However,
we found that the leptin to adiponectin serum concen-
tration ratio (L/A) was signiﬁcantly (approximately sev-
enfold, P = 0.000311) higher in the group of obese
patients. This ratio was also higher (approximately
20-fold, P = 0.0216) when the relative mRNA level was
concerned (Table 1).
For all the 48 patients genotypes at ﬁve polymorphic
sites (three in LEP and two in ADIPOQ) in the 50-ﬂanking
regions of both genes were established in our earlier study
[14]. The comparison of gene expression, including all the
three genotypes (two alternative homozygotes and a het-
erozygote) was possible only for the three most common
SNPs, i.e. -2548G[A, 19A[G( LEP) and -11377C[G
(ADIPOQ). No signiﬁcant differences were found in any of
the studied polymorphisms between the genotypes
(Table 2). The lowest relative mRNA level, as well as
serum leptin concentration, were observed for the GG
(19A[G) and AA (-2548G[A) genotypes. On the other
hand, the 50-ﬂanking polymorphism (-11377C[G) in the
ADIPOQ gene showed the lowest expression (mRNA and
serum protein) for the GG genotype.
Discussion
The expression of adipokine genes in obese subjects is
usually altered—elevated in case of leptin and decreased
for adiponectin [23, 24]. Our observations concerning
leptin gene expression in obese and non-obese patients
conﬁrmed this relationship. In case of adiponectin the
observed differences were not signiﬁcant, may be due to a
small control group of non-obese children (n = 5) included
in our study. However, it should be pointed out that some
discrepancies between adiponectin mRNA and protein
levels were recently described also in the subcutaneous
adipose tissue collected from obese Tunisians [25]. The
authors observed signiﬁcantly decreased serum adiponectin
level in overweight and obese subjects whereas at tran-
scription level no signiﬁcant differences were noticed.
An abnormal gene expression level can be caused by
polymorphisms in 50-ﬂanking sequences, thus adipokine
gene polymorphisms may alter their expression and thus
are considered as potential candidates contributing to
obesity predisposition. The studied polymorphisms, due to
their occurrence within or in a close vicinity to binding
sites for transcription factors, may play a functional role.
Earlier studies showed that haplotype including polymor-
phic site -11377C[G and two other SNPs in the ADIPOQ
gene promoter can interfere with NKXH, CART and zinc–
ﬁnger binding sites and thus has a potential impact on
serum adiponectin concentration [26]. The -2548G[A
polymorphism in the leptin gene is not localized within the
consensus site for any known transcription factor, but it
was suggested that this SNP may affect the function of a
Table 1 A comparison of
leptin and adiponectin gene
expression between obese
subjects and the control group
of non-obese children
a Based on Wilcoxon Rank
Sum Test, signiﬁcant
differences are shown in bold
b Non-signiﬁcant after
Bonferroni correction for
multiple testing (adjusted
P value = 0.0083)
Measurement Obese children and
adolescents (n = 48)
Control group
(n = 5)
P value
a
Median
(1st; 3rd quantile)
Median
(1st; 3rd quantile)
Relative mRNA leptin level
(adipose tissue)
0.037 0.006 0.0296
b
(0.025; 0,079) (0.001; 0.006)
Serum leptin concentration
(ng/ml)
21.850 3.580 0.000276
(16.875; 32.025) (3.470; 4.510)
Relative mRNA adiponectin level
(adipose tissue)
0.034 0.031 0.9152
(0.025; 0.055) (0.019; 0.075)
Serum adiponectin concentration
(lg/ml)
4.590 6.110 0.5842
(3.205; 8.650) (4.640; 7.710)
Relative mRNA leptin to adiponectin
level ratio (L/A)
1.280 0.061 0.0216
b
(0.717; 1.925) (0.060; 0.327)
Serum leptin to adiponectin concentration
ratio (L/A)
4.288 0.623 0.000311
(2.508; 8.714) (0.568; 0.973)
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123binding site for the Sp1 transcription factor which is
localized in the neighborhood [27]. Also several studies of
19A[G polymorphism, localized in 5’UTR of the LEP
gene, indicated its association with serum leptin concen-
tration [18, 19]. Interestingly in our study both SNPs in the
leptin gene were in a strong linkage disequilibrium
(D0 = 0.91). In obese patients four haplotypes were
observed with the following frequencies: -2548A/19G
(0.455), -2548G/19A (0.299), -2548G/19G (0.233) and
-2548A/19A (0.014) but analyses of their putative associ-
ation with leptin gene expression, at mRNA and protein
levels, did not show any signiﬁcant results (P[0.05).
Our recent study showed that the above mentioned SNPs
are also distributed in Polish children and adolescents [14].
Thus, we decided to analyze the relationship between the
observed genotypes and gene expression level, but we did
not ﬁnd any signiﬁcant association. However, there is a
report showing reduced level of circulating leptin in
extremely obese (BMI C 40) French patients with the GG
genotype at 19A[G site [18]. Such a relationship was not
conﬁrmed in comparative studies of African-American and
Caucasian cohorts [19].
The effect of the -2548G[A polymorphism in the LEP
gene on its expression also remains unclear. In a study of
Brazilian women a positive relationship between the G
allele and plasma leptin concentration was reported [11]. A
similar tendency was observed in obese Tunisians [16]. On
the other hand, there are reports indicating that allele A is
related with the elevated leptin expression. Such a rela-
tionship was also found in Polish obese adults [28] and
healthy Greek women [15]. In our studies the highest
expression was observed in GG patients, but the differ-
ences were not signiﬁcant.
In case of the ADIPOQ gene polymorphism
(-11377C[G) there are several reports indicating a
decreased expression of the adiponectin gene in GG sub-
jects [17, 18, 29]. Also in our studies the lowest expression
level in GG patients was observed, but the differences were
again not signiﬁcant.
An interesting observation concerns the ratio of leptin to
adiponectin serum concentrations (L/A). This ratio was
signiﬁcantly elevated in obese patients than in non-obese
subjects. It was already reported that the leptin to adipo-
nectin ratio is an informative marker of atherosclerosis in
obese patients with type 2 diabetes [30]. Later it was
suggested that the L/A ratio may also be considered as a
useful biomarker of insulin resistance [31] and a parameter
characterizing the hormonal proﬁle of obese children and
adolescents, as well as a predisposition to obesity and the
metabolic syndrome in normal-weight patients [32]. Our
observations also showed that the L/A ratio for serum
concentration is signiﬁcantly elevated in obese children
and adolescents. A similar tendency was observed with
regard to the relative mRNA level, but the ratio was only
two-fold higher in obese subjects.
Concluding, our study showed that the studied SNPs are
not conclusive markers for predisposition to obesity in
Polish children and adolescents. On the other hand, we
conﬁrmed that the L/A expression ratio in serum (protein)
and subcutaneous adipose tissue (mRNA) is an informative
index characterizing obesity.
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Table 2 Expression of the leptin and adiponectin genes in obese
subjects, in relation to genotypes at three polymorphic sites
Genotype Relative mRNA
level
in subcutaneous
adipose tissue
median
(1st; 3rd quantile)
Serum concentration
median
(1st; 3rd quantile)
LEP 19A>G ng/ml
AA 0.044 29.650
(n = 4) (0.035; 0.085) (24.600; 33.175)
AG 0.052 28.850
(n = 22) (0.031; 0.077) (19.250; 33.850)
GG 0.030 18.650
(n = 22) (0.016; 0.077) (16.025; 25.325)
P value
a 0.162 0.189
LEP -2548G>A ng/ml
AA 0.035 19.000
(n = 11) (0.027; 0.061) (16.450; 25.150)
AG 0.033 20.800
(n = 23) (0.024; 0.081) (14.100; 32.050)
GG 0.045 29.050
(n = 14) (±0.034; 0.077) (20.775; 33.650)
P value
a 0.739 0.395
ADIPOQ -11377C>G lg/ml
CC 0.040 6.180
(n = 29) (0.027; 0.047) (3.100; 8.680)
CG 0.033 3.920
(n = 15) (0.023; 0.058) (3.615; 6.300)
GG 0.018 3.430
(n = 4) (0.012; 0.035) (2.688; 5.045)
P value
a 0.297 0.452
a Estimated differences were non-signiﬁcant also if dominant or
recessive models were applied
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